Gulden, G.; Sert, B.; Teymur, T.; Ay, Y.; Tiryaki, N.N.; Mishra, A.K.; Ovali, E.; Tarhan, N.; Tastan, C.
CAR-T Cells with Phytohemagglutinin (PHA) Provide Anti-Cancer Capacity with Better Proliferation, Rejuvenated Effector Memory, and Reduced Exhausted T Cell Frequencies. Vaccines 2023, 11, 313.
https://doi.org/10.3390/vaccines11020313
AMA Style
Gulden G, Sert B, Teymur T, Ay Y, Tiryaki NN, Mishra AK, Ovali E, Tarhan N, Tastan C.
CAR-T Cells with Phytohemagglutinin (PHA) Provide Anti-Cancer Capacity with Better Proliferation, Rejuvenated Effector Memory, and Reduced Exhausted T Cell Frequencies. Vaccines. 2023; 11(2):313.
https://doi.org/10.3390/vaccines11020313
Chicago/Turabian Style
Gulden, Gamze, Berranur Sert, Tarik Teymur, Yasin Ay, Nulifer Neslihan Tiryaki, Abhinava K. Mishra, Ercument Ovali, Nevzat Tarhan, and Cihan Tastan.
2023. "CAR-T Cells with Phytohemagglutinin (PHA) Provide Anti-Cancer Capacity with Better Proliferation, Rejuvenated Effector Memory, and Reduced Exhausted T Cell Frequencies" Vaccines 11, no. 2: 313.
https://doi.org/10.3390/vaccines11020313
APA Style
Gulden, G., Sert, B., Teymur, T., Ay, Y., Tiryaki, N. N., Mishra, A. K., Ovali, E., Tarhan, N., & Tastan, C.
(2023). CAR-T Cells with Phytohemagglutinin (PHA) Provide Anti-Cancer Capacity with Better Proliferation, Rejuvenated Effector Memory, and Reduced Exhausted T Cell Frequencies. Vaccines, 11(2), 313.
https://doi.org/10.3390/vaccines11020313
